A Paradigm Shift in Oncology: MIT Researchers Pioneer In-Vivo Immune Cell Reprogramming to Combat Cancer and Autoimmune Disease
Executive Overview In what may mark a watershed moment for modern biotechnology, researchers at the Massachusetts Institute of Technology (MIT) have unveiled a groundbreaking technique that transforms immune cells into…
